RegisterLogin

BMS-1001

CAT: 0804-HY-120647Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-120647Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BMS-1001 is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 exhibits low-toxicity in cells. The IC50 value of BMS-1001 in a homogeneous time-resolved fluorescence (HTRF) binding assay is 2.25 nM[1][2].
CAS Number
[2113650-03-4]
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bms-1001.html
Solubility
10 mM in DMSO
Smiles
OC[C@H](C(O)=O)NCC1=CC(C)=C(OCC2=CC=CC(C3=CC=C4OCCOC4=C3)=C2C)C=C1OCC5=CC=CC(C#N)=C5
Molecular Formula
C35H34N2O7
Molecular Weight
594.65
References & Citations
[1]Skalniak L, et al. Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells. Oncotarget. 2017 Aug 7;8 (42) :72167-72181.|[2]Guzik K, et al. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. J Med Chem. 2017 Jul 13;60 (13) :5857-5867.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-135783-01AT 1001
HY-120620-01BMS-195270
HY-139562BMS-986318
HY-108432BMS-741672
HY-145373BMS-986143
HY-14225BMS-764459
HY-117074BMS-247243
HY-120623-01BMS-284640
HY-P2021BMS 180742
HY-19667BMS-561392

Alternative Products

CatalogName
M13359-01BMS-1001
T10565-01BMS-1001 hydrochloride
A22061-10BMS-1001 10mg
A22061-50BMS-1001 50mg
A22061-25BMS-1001 25mg
562219BMS-1001 HCl
A22061-1BMS-1001 1mg
A22061-5BMS-1001 5mg
A22061-100BMS-1001 100mg
A22061-200BMS-1001 200mg

Popular Products